With multi-industry experience at the intersection of biomedicine, sustainability, and consumer health, Lincoln Yeo brings a distinctive operator’s lens to strategic advisory work across wellness innovation and environmental technologies. As a Strategic Advisor at Avion, he supports ventures and sovereign partners in translating breakthrough science into commercially viable, scalable health and sustainability platforms. His dual background in biomedical innovation and green infrastructure allows him to bridge scientific discovery with sustainable enterprise execution.
Lincoln’s work spans the full spectrum of translational development—from telomere therapeutics and regenerative wellness to eco-materials and green logistics. As the founding Managing Director of Alphacel Singapore, he pioneered the commercialization of SURAN Telomere Therapy™, a Nobel Prize™-recognized biomedical breakthrough now transforming how aging and cellular health are approached across Asia. In parallel, his leadership at The Eco Trading Company positioned green alternatives like RenewPallet and Ecolite as viable industrial-grade substitutes to legacy systems.
His approach integrates biomedical science, ESG strategy, and inclusive product development—unlocking growth in emerging markets by aligning public health priorities, regulatory policy, and sustainable innovation pathways.
“Innovation is only as powerful as its ability to reach people and regenerate systems. I work to ensure every breakthrough is not just scientifically valid—but economically viable, ethically grounded, and environmentally aligned.”
